Covidien has announced the launch of its Nellcor SpO2 single parameter module for use with the Philips IntelliVue patient monitoring platform, according to a news release. The Nellcor SpO2 module ...
New device is the only commercially available bedside monitor designed for home care and sleep study settings DUBLIN, Ireland--(BUSINESS WIRE)-- Covidien (NYSE: COV) today announced CE Mark approval ...
On June 21, Covidien plc ( COV), global innovator and manufacturer of healthcare products, announced the launch of Nellcor SpO 2 single parameter module in North America, European Economic Area (EEA) ...
BOULDER, Colo.--(BUSINESS WIRE)-- Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in mechanical ventilation and respiratory care devices, today ...
Covidien (NYSE: COV), a leading global supplier of healthcare products, today announced the integration of its Nellcor™ OxiMax™ oximetry system into Philips IntelliVue and M-Series patient monitors.
BOULDER, Colo.--(BUSINESS WIRE)-- Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced that its ...
BOULDER, Colo.--(BUSINESS WIRE)--Every year, nearly 7,200 infants are born in the United States with a Critical Congenital Heart Disease (CCHD). 1 It is a condition that is often easily detectable and ...
BOULDER, Colo.--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator of mechanical ventilation and respiratory care devices, today announced ...
Covidien (NYSE: COV) today announced CE Mark approval for its Nellcor™ Bedside SpO 2 Patient Monitoring System, PM100N. The system currently is available in the European Economic Area (EEA), Australia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results